0000000001079148

AUTHOR

Oliver Dangel

showing 1 related works from this author

Effectiveness and safety of dexamphetamine sulfate (Attentin

2021

Abstract Background: Randomized controlled trials have shown that dexamphetamine sulfate (DEX) is efficacious in the treatment of attention-deficit/hyperactivity disorder (ADHD) in children and adolescents; however, data on the effectiveness and safety of DEX in routine practice are scarce. Objective: This study investigated the long-term effectiveness and safety of Attentin® (immediate-release DEX) in children and adolescents with ADHD in routine practice. Methods: ATTENTION was a multicenter, prospective, observational, non-interventional study that enrolled pediatric patients with ADHD (aged 6-17 years) with a clinically inadequate response to previous methylphenidate (MPH) treatment. Pa…

Pediatricsmedicine.medical_specialtydexamphetamineRC435-571Impulsivitylaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialchildrenlawRating scale030225 pediatricsmental disordersmedicineClinical endpointADHDPsychology0501 psychology and cognitive sciencesadolescentsPsychiatryMethylphenidatebusiness.industry05 social sciences3. Good healthBF1-990Blood pressureMedicineObservational studyOnset of actionmedicine.symptombusiness050104 developmental & child psychologymedicine.drugScandinavian journal of child and adolescent psychiatry and psychology
researchProduct